Hyperparathyroidism

46,693views

test

00:00 / 00:00

Hyperparathyroidism

D115

D115

Systemic lupus erythematosus
Turner syndrome
Klinefelter syndrome
Fragile X syndrome
Prader-Willi syndrome
Angelman syndrome
Endocrine system anatomy and physiology
Restrictive lung diseases
Down syndrome (Trisomy 21)
Pyloric stenosis
Innate immune system
Antibody classes
HIV (AIDS)
Myasthenia gravis
Meningitis
Multiple sclerosis
Guillain-Barre syndrome
Delirium
Lewy body dementia
Alzheimer disease
Epilepsy
Normal pressure hydrocephalus
Huntington disease
Parkinson disease
Concussion and traumatic brain injury
Lambert-Eaton myasthenic syndrome
Major depressive disorder
Generalized anxiety disorder
Schizophrenia
Spina bifida
Phenylketonuria (NORD)
Tay-Sachs disease (NORD)
Cerebral palsy
Hyperparathyroidism
Hypoparathyroidism
Diabetes insipidus
Graves disease
Diabetes mellitus
Cushing syndrome
Primary adrenal insufficiency
Breast cancer
Benign prostatic hyperplasia
Ovarian cyst
Pneumonia
Chronic bronchitis
Asthma
Emphysema
Pulmonary embolism
Pneumothorax
Pleural effusion
Bronchiectasis
Acute respiratory distress syndrome
Mycobacterium tuberculosis (Tuberculosis)
Cor pulmonale
Bacterial epiglottitis
Laryngomalacia
Respiratory syncytial virus
Cystic fibrosis
Sudden infant death syndrome
Disseminated intravascular coagulation
Sickle cell disease (NORD)
Chronic leukemia
Acute leukemia
Myocardial infarction
Deep vein thrombosis
Hypoplastic left heart syndrome
Angina pectoris
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Iron deficiency anemia
Aplastic anemia
Autoimmune hemolytic anemia
Polycythemia vera (NORD)
Immune thrombocytopenia
Epstein-Barr virus (Infectious mononucleosis)
Non-Hodgkin lymphoma
Hodgkin lymphoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Beta-thalassemia
Alpha-thalassemia
Raynaud phenomenon
Arterial disease
Peripheral artery disease
Coronary artery disease: Pathology review
Pericarditis and pericardial effusion
Rheumatic heart disease
Heart failure
Patent ductus arteriosus
Ventricular septal defect
Pulmonary valve disease
Kawasaki disease
Tetralogy of Fallot
Urinary tract infections: Clinical
Kidney stones
Chronic kidney disease
Nephrotic syndromes: Pathology review
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Neurogenic bladder
Bladder exstrophy
Hypospadias and epispadias
Polycystic kidney disease
Hemolytic-uremic syndrome
Nephroblastoma (Wilms tumor)
Vesicoureteral reflux
Renal failure: Pathology review
Gastrointestinal bleeding: Pathology review
Gastroesophageal reflux disease (GERD)
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Zollinger-Ellison syndrome
Wilson disease
Malabsorption syndromes: Pathology review
Ulcerative colitis
Crohn disease
Irritable bowel syndrome
Diverticulosis and diverticulitis
Appendicitis
Portal hypertension
Intussusception
Celiac disease
Gastric cancer
Acute pancreatitis
Chronic pancreatitis
Chronic cholecystitis
Acute cholecystitis
Gallstones
Jaundice
Hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Hepatitis C virus
Cirrhosis
Biliary atresia
Hirschsprung disease
Paget disease of bone
Osteoporosis
Osteoarthritis
Atopic dermatitis
Varicella zoster virus
Osteomalacia and rickets
Bone tumors
Rheumatoid arthritis
Ankylosing spondylitis
Gout
Fibromyalgia
Hypothyroidism
Hypomagnesemia
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Myalgias and myositis: Pathology review
Polymyositis
Dermatomyositis
Lordosis, kyphosis, and scoliosis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Muscular dystrophy
Scleroderma
Psoriasis
Lichen planus
Pemphigus vulgaris
Acne vulgaris
Erythema multiforme
Stevens-Johnson syndrome
Lyme Disease
Herpes simplex virus
Skin cancer
Human herpesvirus 8 (Kaposi sarcoma)
Rubella virus
Measles virus
Burns
Shock
Cri du chat syndrome
Prostate cancer
Post-traumatic stress disorder
Wiskott-Aldrich syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Truncus arteriosus
Membranoproliferative glomerulonephritis
Poststreptococcal glomerulonephritis
Menstrual cycle

Assessments

Flashcards

0 / 8 complete

USMLE® Step 1 questions

0 / 3 complete

High Yield Notes

5 pages

Flashcards

Hyperparathyroidism

0 of 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

A 74-year-old woman is brought to the emergency department because of generalized muscle aching, weakness and pain in the left hand. The symptoms started gradually a few months ago and have been progressing over time. Past medical history is notable for uncontrolled hypertension, type 2 diabetes mellitus and end-stage renal disease. Her medications include amlodipine, hydralazine and insulin glargine. Her last recorded glomerular filtration rate is 20 mL/min, and she has been receiving dialysis three times per week for the past 2 years. A radiograph of the patient’s hands is shown below:

 Routine blood work is performed. Which of the following sets of findings will most likely be seen in this patient? 

External References

First Aid

2024

2023

2022

2021

Abdominal pain

hyperparathyroidism p. 342

Acute pancreatitis p. 404

hyperparathyroidism p. 342

Alkaline phosphatase (ALP) p. 397, 468

hyperparathyroidism and p. 342

cAMP (cyclic adenosine monophosphate)

hyperparathyroidism p. 342

Depression

hyperparathyroidism p. 342

Hypercalcemia p. 609

hyperparathyroidism p. 342

Hypercalciuria

hyperparathyroidism p. 342

Hyperparathyroidism p. 342

associations p. 732

calcium pyrophosphate deposition disease p. 473

cinacalcet for p. 361

lab findings p. 728

lab values in p. 467

osteoporosis p. 467

renal osteodystrophy and p. 622

Hyperphosphatemia p. 609

hyperparathyroidism (secondary) p. 342

Hypocalcemia p. 335, 609

hyperparathyroidism p. 342

Hypophosphatemia p. 609

hyperparathyroidism p. 342

Kidney stones p. 620

hyperparathyroidism p. 342

Pancreatitis p. 404

hyperparathyroidism as cause p. 342

Parathyroid adenomas

hyperparathyroidism caused by p. 342

Parathyroid hormone (PTH) p. 334

in hyperparathyroidism p. 342

Polyuria p. 618

hyperparathyroidism p. 342

Tertiary hyperparathyroidism p. 342

Vitamin D deficiency p. 348

hyperparathyroidism p. 469

Transcript

Watch video only

With hyperparathyroidism, “hyper” refers to over, and “parathyroid” refers to the parathyroid glands, so hyperparathyroidism refers to a condition where there is an overproduction of parathyroid hormone.

Parathyroid hormone comes from the parathyroid glands which are buried within the thyroid gland, and their main job is to keep blood calcium levels stable.

Now, the majority of the extracellular calcium, the calcium in the blood and interstitium, is split almost equally between two groups - calcium that is diffusible and calcium that is not diffusible.

Diffusible calcium is small enough to diffuse across cell membranes and is separated into two subcategories.

The first is free-ionized calcium, which is involved in all sorts of cellular processes like neuronal action potentials, contraction of skeletal, smooth, and cardiac muscle, hormone secretion, and blood coagulation, all of which are tightly regulated by enzymes and hormones.

The second category is complexed calcium, which is where the positively charged calcium is ionically linked to tiny negatively charged molecules like oxalate, which is a small anion that are normally found in our blood in small amounts.

The complexed calcium forms a molecule that’s electrically neutral but unlike free-ionized calcium it’s not useful for cellular processes.

Both of these are called diffusible because they’re small enough to diffuse across cell membranes.

Finally there’s the non-diffusible calcium which is bound to negatively charged proteins like albumin.

The resulting protein-calcium complex is too large and charged to cross membranes, leaving this calcium also uninvolved in cellular processes.

Changes in the body’s levels of extracellular calcium are detected by a surface receptor in parathyroid cells that’s called the calcium-sensing receptor.

These changes affect the amount of parathyroid hormone that’s released by the parathyroid gland.

The parathyroid hormone gets the bones to release calcium, it gets the kidneys to reabsorb more calcium so it's not lost in the urine, and it synthesizes calcitriol, which is also known as 1,25-dihydroxycholecalciferol, or active vitamin D.

Active vitamin D then goes on to cause the gastrointestinal tract to increase calcium absorption.

Altogether, these effects help to keep the extracellular levels of calcium within a narrow range that’s between 8.5 to 10 mg/dl.

So there are three types of hyperparathyroidism - primary, secondary, and tertiary.

In primary hyperparathyroidism, the parathyroid gland is responsible for the problem, because it makes parathyroid hormone independently of the calcium level.

Excess parathyroid hormone stimulates osteoclasts to break down bone and makes the kidneys hold on to calcium and get rid of phosphate - resulting in hypercalcemia and hypophosphatemia.

The excess calcium makes neurons less excitable, which leads to slower muscle contractions, and diminishes neuron firing in the central nervous system.

It also causes hypercalciuria - excess loss of calcium in urine - which can lead to dehydration. This is because there is just too much calcium to be reabsorbed by the kidneys.

Most often, primary hyperparathyroidism is caused by a single parathyroid adenoma, or benign tumor, which happens either because of a genetic mutation in a single cell or because of an inherited disorder like multiple endocrine neoplasia, which affects the parathyroid, pancreas, and pituitary glands.

Rarely, primary hyperparathyroidism is caused by hyperplasia, where parathyroid cells divide excessively causing growth of the glands, or by a parathyroid carcinoma, a cancerous tumor.

In secondary hyperparathyroidism, the parathyroid gland is normal, but it makes excess parathyroid hormone in response to chronic hypocalcemia - a low level of calcium - from another cause.

Summary

Hyperparathyroidism is a condition in which the parathyroid glands produce too much parathyroid hormone (PTH), which regulates calcium levels in the blood. Hyperparathyroidism can be primary, secondary, or even tertiary.

Primary hyperparathyroidism usually results from PTH secretion by a parathyroid adenoma. It is characterized by excess PTH that leads to high blood calcium levels (hypercalcemia), bone mass loss, kidney stones, and other health problems, such as psychiatric issues.

Secondary hyperparathyroidism develops when there are conditions like chronic kidney disease, which can lead to low calcium, high phosphate, and low vitamin D levels. It is mainly characterized by osteodystrophy, in which there is bone weakening associated with bone pain and deformation.

Finally, there is tertiary hyperparathyroidism, which occurs because of chronic secondary hyperparathyroidism from kidney disease. This leads to hypercalcemia and phosphate imbalances.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications" Endocrine Reviews (2001)
  7. "Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients" Cochrane Database of Systematic Reviews (2014)